cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.

Employees - 42, CEO - T. Ronan Kennedy, Sector - Healthcare, Country - US, Market Cap -

Altman ZScore(max is 10): -21.87, Piotroski Score(max is 10): 3, Working Capital: $2013482, Total Assets: $9895256, Retained Earnings: $-179090682, EBIT: -1271356, Total Liabilities: $3784753, Revenue: $19026064

- Current Price $ - Analyst Target Price $